A Finnish study recently examined genetic mutations and how they could impact some of the most common diabetes complications, including nephropathy and retinopathy. Researchers found that people living with type 1 diabetes who also have a specific mutation in their SLC19A3 gene experienced some significant benefits. They were less likely to develop both diabetic nephropathy and retinopathy.
This study was completed using an extensive database including information about diabetes patients as well as their complications. Although several data sets were used, the results were consistent even when the study was repeated. This shows promising results for ways to prevent diabetes complications in the future.
These findings were published in Diabetes on December 30, 2015.